Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fenchone SCHEMBL856607 | 1.00 | MEN1 (0.38) | MEN1ALDH1A1LMNAMAPTKMT2A | |
| (+)-Fenchone SCHEMBL856608 | 1.00 | MEN1 (0.38) | MEN1ALDH1A1LMNAMAPTKMT2A | |
| (L)-Fenchone SCHEMBL18221219 | 1.00 | MEN1 (0.38) | MEN1ALDH1A1LMNAMAPTKMT2A | |
| Fenchone SCHEMBL527930 | 1.00 | MEN1 (0.38) | MEN1ALDH1A1LMNAMAPTKMT2A | |
| (-)-Fenchone SCHEMBL7997210 | 1.00 | MEN1 (0.38) | MEN1ALDH1A1LMNAMAPTKMT2A | |
| SCHEMBL19388309 | 0.87 | TSHR (0.35) | MEN1ALDH1A1LMNAMAPTKMT2A | |
| SCHEMBL11802436 | 0.86 | MAPT (0.40) | MEN1ALDH1A1LMNAMAPTKMT2A | |
| SCHEMBL4140998 | 0.80 | MAPT (0.32) | MAPT | |
| SCHEMBL27818456 | 0.78 | MEN1 (0.35) | MEN1ALDH1A1LMNAMAPTKMT2A | |
| SCHEMBL6623292 | 0.76 | KMT2A (0.41) | MEN1ALDH1A1LMNAMAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1500649-B1 | Process for performing an in-situ-quench reaction | LONZA AG (CH) | 2013-06-19 | — | — | EP | disclosed |